Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Pulmonary pharmacology and therapeutics

  • Pulmonary pharmacology and therapeutics
  • Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
    Caroline E. Wright, Simon D. Fraser, Kayleigh Brindle, Alyn H. Morice, Simon P. Hart, Michael G. Crooks
    ERJ Open Research Oct 2017, 3 (4) 00100-2017; DOI: 10.1183/23120541.00100-2017
  • Pembrolizumab-induced pneumonitis
    Vincent Leroy, Carole Templier, Jean-Baptiste Faivre, Arnaud Scherpereel, Clement Fournier, Laurent Mortier, Lidwine Wemeau-Stervinou
    ERJ Open Research Apr 2017, 3 (2) 00081-2016; DOI: 10.1183/23120541.00081-2016
  • Discordance in investigator-reported and adjudicated sudden death in TIOSPIR
    Robert A. Wise, Peter R. Kowey, George Austen, Achim Mueller, Norbert Metzdorf, Andy Fowler, Lorcan P. McGarvey
    ERJ Open Research Jan 2017, 3 (1) 00073-2016; DOI: 10.1183/23120541.00073-2016
  • β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
    Catherina L. Chang, Conroy Wong, Lutz Beckert, Eskandarain Shafuddin, Richard Beasley, Robert Young, Robert J. Hancox
    ERJ Open Research Jan 2017, 3 (1) 00090-2016; DOI: 10.1183/23120541.00090-2016
  • Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler
    David B. Price, Gene Colice, Elliot Israel, Nicolas Roche, Dirkje S. Postma, Theresa W. Guilbert, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V. Hillyer, Victoria Thomas, Richard J. Martin
    ERJ Open Research Apr 2016, 2 (2) 00106-2015; DOI: 10.1183/23120541.00106-2015
  • VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study
    Thierry Berghmans, Jean-Jacques Lafitte, Arnaud Scherpereel, Lieveke Ameye, Marianne Paesmans, Anne-Pascale Meert, Benoit Colinet, Christian Tulippe, Luc Willems, Nathalie Leclercq, Jean-Paul Sculier, for the European Lung Cancer Working Party
    ERJ Open Research Oct 2015, 1 (2) 00029-2015; DOI: 10.1183/23120541.00029-2015
  • Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models
    Roland Hubaux, Fabian Vandermeers, Jean-Philippe Cosse, Cecilia Crisanti, Veena Kapoor, Steven M. Albelda, Céline Mascaux, Philippe Delvenne, Pascale Hubert, Luc Willems
    ERJ Open Research Oct 2015, 1 (2) 00028-2015; DOI: 10.1183/23120541.00028-2015
  • Revisiting early intervention in adult asthma
    Tari Haahtela, Olof Selroos, Paul M. O'Byrne
    ERJ Open Research May 2015, 1 (1) 00022-2015; DOI: 10.1183/23120541.00022-2015

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Acute lung injury and critical care (21)
  • Asthma and allergy (108)
  • CF and non-CF bronchiectasis (71)
  • COPD and smoking (186)
  • Epidemiology, occupational and environmental lung disease (42)
  • Genetics (12)
  • Interstitial and orphan lung disease (93)
  • Lung biology and experimental studies (43)
  • Lung cancer (51)
  • Lung imaging (24)
  • Lung structure and function (47)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (53)
  • Pulmonary pharmacology and therapeutics (58)
  • Pulmonary vascular disease (36)
  • Respiratory clinical practice (69)
  • Respiratory infections and tuberculosis (161)
  • Sleep medicine (37)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series
  • COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society